UroGen Pharma Ltd. (URGN)
UroGen Pharma Ltd. (URGN) has reported earnings 28 times since Feb 28, 2019. The stock moves an average of ±7.48% the day after reporting, closing higher 60.7% of the time. Its largest post-earnings gain was +21.91% (Nov 06, 2025) and its largest decline was -22.95% (Nov 15, 2021). The next earnings report is predicted for 2026-08-10 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
28
Avg Abs. Movement
±7.48%
Positive %
60.7%
Negative %
39.3%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 06, 2026 | ☀ PRE | $25.15 | $27.43 | $26.18 | 194,260 | +9.86% | open_in_new |
| Mar 02, 2026 | ☀ PRE | $21.66 | $21.69 | $19.02 | 2,696,900 | -12.35% | open_in_new |
| Nov 06, 2025 | ☀ PRE | $18.28 | $23.64 | $23.54 | 4,249,900 | +21.91% | open_in_new |
| Aug 07, 2025 | ☀ PRE | $19.33 | $19.76 | $18.59 | 1,826,000 | -7.1% | open_in_new |
| May 12, 2025 | ☀ PRE | $9.90 | $11.41 | $11.14 | 959,200 | +7.32% | open_in_new |
| Mar 10, 2025 | ☀ PRE | $9.11 | $9.99 | $9.92 | 461,700 | +1.02% | open_in_new |
| Nov 06, 2024 | ☀ PRE | $13.25 | $13.37 | $12.24 | 687,300 | +0.25% | open_in_new |
| Aug 13, 2024 | ☀ PRE | $14.18 | $15.77 | $14.96 | 869,300 | +3.1% | open_in_new |
| May 13, 2024 | ☀ PRE | $10.90 | $13.30 | $13.07 | 572,300 | +2.59% | open_in_new |
| Mar 14, 2024 | ☀ PRE | $16.77 | $16.89 | $14.33 | 640,400 | -17.97% | open_in_new |
| Nov 14, 2023 | ☀ PRE | $12.17 | $12.17 | $11.68 | 325,900 | -0.68% | open_in_new |
| Aug 10, 2023 | ☀ PRE | $21.18 | $21.89 | $21.21 | 528,300 | +2.46% | open_in_new |
| May 11, 2023 | ☀ PRE | $11.67 | $12.42 | $12.42 | 217,100 | +8% | open_in_new |
| Mar 22, 2023 | ☽ POST | $8.83 | $9.02 | $8.17 | 184,600 | +2.33% | open_in_new |
| Nov 10, 2022 | ☀ PRE | $10.81 | $10.87 | $9.18 | 236,600 | -16.32% | open_in_new |
| Aug 11, 2022 | ☀ PRE | $8.36 | $8.98 | $8.33 | 64,500 | -6.51% | open_in_new |
| May 10, 2022 | ☀ PRE | $6.18 | $6.85 | $6.57 | 184,000 | +5.97% | open_in_new |
| Mar 21, 2022 | ☀ PRE | $9.50 | $10.00 | $9.02 | 201,100 | +0.11% | open_in_new |
| Nov 15, 2021 | ☀ PRE | $18.41 | $18.93 | $14.74 | 240,400 | -22.95% | open_in_new |
| Aug 04, 2021 | ☀ PRE | $15.41 | $16.86 | $15.30 | 311,500 | -2.61% | open_in_new |
| May 13, 2021 | ☀ PRE | $18.17 | $18.17 | $15.38 | 495,500 | -15.31% | open_in_new |
| Mar 18, 2021 | ☀ PRE | $20.64 | $20.85 | $18.05 | 403,200 | -7.44% | open_in_new |
| Nov 09, 2020 | ☀ PRE | $25.94 | $25.94 | $24.89 | 145,500 | +4.98% | open_in_new |
| Aug 10, 2020 | ☀ PRE | $24.50 | $26.52 | $26.42 | 432,000 | +14.08% | open_in_new |
| Nov 12, 2019 | ☀ PRE | $26.00 | $28.40 | $27.51 | 472,000 | +13.58% | open_in_new |
| Aug 09, 2019 | ☀ PRE | $32.60 | $33.15 | $32.08 | 164,800 | -1.69% | open_in_new |
| May 09, 2019 | ☀ PRE | $38.00 | $39.97 | $38.21 | 179,200 | +0.61% | open_in_new |
| Feb 28, 2019 | ☀ PRE | $38.49 | $40.41 | $38.48 | 445,900 | +0.26% | open_in_new |
Earnings Count
28
Total earnings in dataset
Avg Abs. Movement
±7.48%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 144 | 20260609 | open_in_new SEC.gov |
| 4 | 20260609 | open_in_new SEC.gov |
| 8-K | 20260602 | open_in_new SEC.gov |
| 4 | 20260527 | open_in_new SEC.gov |
| ARS | 20260527 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260515 | open_in_new SEC.gov |
| 144 | 20260508 | open_in_new SEC.gov |
| 10-Q | 20260506 | open_in_new SEC.gov |
| 8-K | 20260506 | open_in_new SEC.gov |
Frequently asked about URGN earnings
When does UroGen Pharma Ltd. report earnings next? expand_more
UroGen Pharma Ltd. (URGN)'s next earnings date is approximate for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does URGN stock move after earnings? expand_more
Over 28 reports, URGN has moved an average of ±7.48% the session after earnings, closing higher 60.7% of the time.
What was URGN's biggest post-earnings move? expand_more
URGN's largest post-earnings gain on record was +21.91% on Nov 06, 2025, and its largest decline was -22.95% on Nov 15, 2021.
Where can I find UroGen Pharma Ltd.'s SEC filings? expand_more
All of UroGen Pharma Ltd.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right